• Open Daily: 10am - 10pm
    Alley-side Pickup: 10am - 7pm

    3038 Hennepin Ave Minneapolis, MN
    612-822-4611

Open Daily: 10am - 10pm | Alley-side Pickup: 10am - 7pm
3038 Hennepin Ave Minneapolis, MN
612-822-4611
The Impact of Off-Label, Compassionate, and Unlicensed Use on Health Care Laws in Preselected Countries

The Impact of Off-Label, Compassionate, and Unlicensed Use on Health Care Laws in Preselected Countries

Paperback

Health GeneralGeneral Law

ISBN10: 3838201353
ISBN13: 9783838201351
Publisher: Ibidem Press
Published: Jul 1 2010
Pages: 174
Weight: 0.48
Height: 0.38 Width: 5.83 Depth: 8.27
Language: English
In times of situational therapeutic impasse, health care professionals (HCPs) are under pressure to conduct off-label, unlicensed and compassionate drug use--generally summarized under the term non-licensed drug use (NDU). Liability, contractual and penal risks pose a problem when treating a patient in a non-licensed way. There is a knowledge gap about institutional and governmental methods to resolve these problems. Different countries have developed strategies to manage NDU. Vanessa Platé gives a comprehensive overview of practices Canada, the U.S., the U.K., Japan, France, Germany, Switzerland, Austria, and the transnational E.U. A must-read for everyone interested in the discussion on how to administer the best treatment, especially regarding early access to yet unapproved treatments.

Also in

General Law